91 related articles for article (PubMed ID: 11128030)
1. Selection and isolation of cells for optimal growth in hollow fiber bioreactors.
Gramer MJ; Britton TL
Hybridoma; 2000 Oct; 19(5):407-12. PubMed ID: 11128030
[TBL] [Abstract][Full Text] [Related]
2. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
Gramer MJ; Maas J
Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
[TBL] [Abstract][Full Text] [Related]
4. Screening tool for hollow-fiber bioreactor process development.
Gramer MJ; Poeschl DM
Biotechnol Prog; 1998 Mar; 14(2):203-9. PubMed ID: 9548770
[TBL] [Abstract][Full Text] [Related]
5. Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.
Gramer MJ; Britton TL
Biotechnol Bioeng; 2002 Aug; 79(3):277-83. PubMed ID: 12115416
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cell growth in T-flasks, in micro hollow fiber bioreactors, and in an industrial scale hollow fiber bioreactor system.
Gramer MJ; Poeschl DM
Cytotechnology; 2000 Oct; 34(1-2):111-9. PubMed ID: 19003385
[TBL] [Abstract][Full Text] [Related]
7. A new serum-free medium for monoclonal antibody production.
Wolfe RA; Braatz JA; Miller DA; Heifetz AH
Biotechniques; 1988 Jan; 6(1):62-7. PubMed ID: 3273394
[TBL] [Abstract][Full Text] [Related]
8. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of metabolic parameters and optimization of antibody production using high cell density hybridoma in hollow fiber bioreactors.
Liu CH; Liu YX; Kumari M; Wu WC
Biotechnol Lett; 2019 Sep; 41(8-9):963-977. PubMed ID: 31325004
[TBL] [Abstract][Full Text] [Related]
10. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
Cherlet M; Marc A
Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
[TBL] [Abstract][Full Text] [Related]
11. Predictive control of hollow-fiber bioreactors for the production of monoclonal antibodies.
Dowd JE; Weber I; Rodriguez B; Piret JM; Kwok KE
Biotechnol Bioeng; 1999 May; 63(4):484-92. PubMed ID: 10099629
[TBL] [Abstract][Full Text] [Related]
12. [Continuous production of anti-hepatitis B surface antigen monoclonal antibody in hollow fiber perfusion bioreactor].
Meng MH; Chen GC; Hsieh JH; Yueh Y; Chen SC; Chang TH; Tsao D
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):125-40. PubMed ID: 3072154
[TBL] [Abstract][Full Text] [Related]
13. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
Kurkela R; Fraune E; Vihko P
Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
[TBL] [Abstract][Full Text] [Related]
14. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
Zhou W; Cai S
Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production.
Jackson LR; Trudel LJ; Fox JG; Lipman NS
J Immunol Methods; 1996 Feb; 189(2):217-31. PubMed ID: 8613673
[TBL] [Abstract][Full Text] [Related]
16. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
Ozturk SS; Palsson BO
Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
[TBL] [Abstract][Full Text] [Related]
17. Hybridoma cell growth and monoclonal antibody yield in serum-free media.
Simonson L; Morton H; Reedy E
Cytobios; 1994; 77(310):159-65. PubMed ID: 8020250
[TBL] [Abstract][Full Text] [Related]
18. Large-scale production of murine monoclonal antibodies using hollow fiber bioreactors.
Evans TL; Miller RA
Biotechniques; 1988 Sep; 6(8):762-7. PubMed ID: 3273638
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel membrane aerated hollow-fiber microbioreactor.
Villain L; Meyer L; Kroll S; Beutel S; Scheper T
Biotechnol Prog; 2008; 24(2):367-71. PubMed ID: 18386917
[TBL] [Abstract][Full Text] [Related]
20. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
